These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 17216817)

  • 61. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
    Mulligan AM; O'Malley FP; Ennis M; Fantus IG; Goodwin PJ
    Breast Cancer Res Treat; 2007 Nov; 106(1):39-47. PubMed ID: 17221153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic factors for breast cancer and their use in the clinical setting.
    Kapoor A; Vogel VG
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
    Li X; Lewis MT; Huang J; Gutierrez C; Osborne CK; Wu MF; Hilsenbeck SG; Pavlick A; Zhang X; Chamness GC; Wong H; Rosen J; Chang JC
    J Natl Cancer Inst; 2008 May; 100(9):672-9. PubMed ID: 18445819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
    D'Alessandro C; Dellapasqua S; Orlando L; Santoro L; Maisonneuve P; Torrisi R; Balduzzi A; Scarano E; Ghisini R; Peruzzotti G; Goldhirsch A; Colleoni M
    Breast J; 2008; 14(5):435-41. PubMed ID: 18821931
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study.
    Dragun AE; Pan J; Rai SN; Kruse B; Jain D
    Am J Clin Oncol; 2011 Jun; 34(3):231-7. PubMed ID: 20805742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
    Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
    Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
    Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
    Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.
    Kalfon B; Fineberg S; Gu Y; Anand K; Dalal A ; Jones J; Sparano JA
    Clin Breast Cancer; 2001 Apr; 2(1):67-72. PubMed ID: 11899385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
    Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Role of palliative surgery in complex treatment for disseminated breast cancer].
    Orlova RV; Moiseenko VM; Gafton GI; Kochnev VA; Shchukin VV; Semiglazov VV; Raskin GA
    Vopr Onkol; 2007; 53(5):521-5. PubMed ID: 18154113
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer.
    Jung SY; Han W; Lee JW; Ko E; Kim E; Yu JH; Moon HG; Park IA; Oh DY; Im SA; Kim TY; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2009 May; 16(5):1112-21. PubMed ID: 19219507
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Breast cancer during pregnancy: maternal and fetal outcomes.
    Cardonick E; Dougherty R; Grana G; Gilmandyar D; Ghaffar S; Usmani A
    Cancer J; 2010; 16(1):76-82. PubMed ID: 20164696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany.
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Dittmer C; Wedel B; Mebes I; Diedrich K; Fischer D
    Arch Gynecol Obstet; 2012 Aug; 286(2):489-93. PubMed ID: 22491806
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
    Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A
    Breast; 2007 Jun; 16(3):280-92. PubMed ID: 17257844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Tumoral vascular density in breast tumors and their effect on recurrence-free survival].
    Obermair A; Czerwenka K; Kurz C; Kaider A; Sevelda P
    Chirurg; 1994 Jul; 65(7):611-5. PubMed ID: 7523041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.